AI Accelerates Cancer Research: ACS Partners with Layer Health for LLM Data Extraction

The American Cancer Society (ACS) and Layer Health have announced a significant multi-year collaboration that aims to accelerate cancer research through artificial intelligence. This partnership will utilize large language models (LLMs) to extract critical clinical data from patient medical records, dramatically improving the efficiency of research processes.

The collaboration builds upon a successful pilot program focused on breast cancer patients, which demonstrated the platform's exceptional ability to extract complex concepts from patient charts with accuracy exceeding human capabilities. This technological advancement addresses a long-standing challenge in medical research.

Traditionally, gathering information from medical records for research purposes has been a labor-intensive and time-consuming process, heavily dependent on manual effort. Previous machine learning approaches have shown limitations in scalability and struggled to generalize effectively across diverse hospital systems.

Through this partnership, ACS will implement Layer Health's advanced LLM-powered data abstraction platform to extract clinical data from thousands of medical charts belonging to patients enrolled in ACS research studies. This includes the Cancer Prevention Study-3, a landmark population study involving 300,000 participants, thousands of whom have been diagnosed with cancer and provided their medical records for research purposes.

Layer Health's platform promises to deliver accurate, reliable, and high-quality data in significantly less time than conventional methods. This efficiency improvement will enable ACS researchers to uncover deeper insights from medical records and potentially accelerate advancements in patient outcomes.

"This collaboration with the American Cancer Society marks a significant milestone in how technology can support the fight against cancer," said Dr. David Sontag, CEO, Layer Health. "We are proud to provide a solution that not only streamlines the research process but also empowers organizations like the ACS to scale their insights and accelerate their groundbreaking work."

The partnership represents a notable advancement in applying artificial intelligence to medical research, potentially setting a new standard for how healthcare organizations can leverage technology to enhance their research capabilities. By automating the extraction of complex clinical data, researchers can focus more resources on analysis and developing new insights rather than on the tedious process of manual data collection.

As this collaboration progresses, both organizations anticipate that the increased efficiency in data processing will lead to faster research cycles and potentially accelerate the discovery of new treatments and prevention strategies for cancer patients.